The Role of Fibroblast Growth Factor 23 in Regulation of Phosphate Balance

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2024 Jun 14

PMID 38874635

Authors

Raphael Wilson

Neije Mukherjee-Roy

Jyothsna Gattineni

Affiliations

Soon will be listed here.

Abstract

Phosphate is essential for numerous biological processes, and serum levels are tightly regulated to accomplish these functions. The regulation of serum phosphate in a narrow physiological range is a well-orchestrated process and involves the gastrointestinal (GI) tract, bone, kidneys, and several hormones, namely, parathyroid hormone, fibroblast growth factor 23 (FGF23), and 1,25-dihydroxyvitamin D (1,25 Vitamin D). Although primarily synthesized in the bone, FGF23, an endocrine FGF, acts on the kidney to regulate phosphate and Vitamin D homeostasis by causing phosphaturia and reduced levels of 1,25 Vitamin D. Recent studies have highlighted the complex regulation of FGF23 including transcriptional and post-translational modification and kidney-bone cross talk. Understanding FGF23 biology has led to the identification of novel therapeutic agents to treat diseases that disrupt phosphate metabolism secondary to FGF23. The focus of this review is to provide an overview of phosphate homeostasis, FGF23 biology, and the role of FGF23 in phosphate balance.

References

Murer H, Forster I, Biber J . The sodium phosphate cotransporter family SLC34. Pflugers Arch. 2003; 447(5):763-7. DOI: 10.1007/s00424-003-1072-5. View

Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy C, Bross R, Shinaberger C . Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010; 5(3):519-30. DOI: 10.2215/CJN.06080809. View

Gattineni J, Baum M . Genetic disorders of phosphate regulation. Pediatr Nephrol. 2012; 27(9):1477-87. PMC: 3407352. DOI: 10.1007/s00467-012-2103-2. View

Kruse K, KRACHT U, Gopfert G . Renal threshold phosphate concentration (TmPO4/GFR). Arch Dis Child. 1982; 57(3):217-23. PMC: 1627603. DOI: 10.1136/adc.57.3.217. View

HILFIKER H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J . Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A. 1998; 95(24):14564-9. PMC: 24413. DOI: 10.1073/pnas.95.24.14564. View

Hattenhauer O, Traebert M, Murer H, Biber J . Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol. 1999; 277(4):G756-62. DOI: 10.1152/ajpgi.1999.277.4.G756. View

Danisi G, Bonjour J, Straub R . Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1,25-dihydroxycholecalciferol. Pflugers Arch. 1980; 388(3):227-32. DOI: 10.1007/BF00658486. View

Peacock M . Phosphate Metabolism in Health and Disease. Calcif Tissue Int. 2020; 108(1):3-15. DOI: 10.1007/s00223-020-00686-3. View

Virkki L, Biber J, Murer H, Forster I . Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol. 2007; 293(3):F643-54. DOI: 10.1152/ajprenal.00228.2007. View

10.

Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D . Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2005; 78(2):193-201. PMC: 1380229. DOI: 10.1086/499410. View

11.

Bergwitz C, Roslin N, Tieder M, Loredo-Osti J, Bastepe M, Abu-Zahra H . SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2005; 78(2):179-92. PMC: 1380228. DOI: 10.1086/499409. View

12.

Beck L, Karaplis A, Amizuka N, Hewson A, Ozawa H, Tenenhouse H . Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A. 1998; 95(9):5372-7. PMC: 20268. DOI: 10.1073/pnas.95.9.5372. View

13.

Wagner C, Rubio-Aliaga I, Hernando N . Renal phosphate handling and inherited disorders of phosphate reabsorption: an update. Pediatr Nephrol. 2017; 34(4):549-559. DOI: 10.1007/s00467-017-3873-3. View

14.

Jennings M . Role of transporters in regulating mammalian intracellular inorganic phosphate. Front Pharmacol. 2023; 14:1163442. PMC: 10097972. DOI: 10.3389/fphar.2023.1163442. View

15.

Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y . FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004; 19(3):429-35. DOI: 10.1359/JBMR.0301264. View

16.

Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S . Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001; 98(11):6500-5. PMC: 33497. DOI: 10.1073/pnas.101545198. View

17.

White K, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom T, Econs M . Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 2001; 60(6):2079-86. DOI: 10.1046/j.1523-1755.2001.00064.x. View

18.

Carpenter T, Whyte M, Imel E, Boot A, Hogler W, Linglart A . Burosumab Therapy in Children with X-Linked Hypophosphatemia. N Engl J Med. 2018; 378(21):1987-1998. DOI: 10.1056/NEJMoa1714641. View

19.

Asada M, Shinomiya M, Suzuki M, Honda E, Sugimoto R, Ikekita M . Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim Biophys Acta. 2008; 1790(1):40-8. DOI: 10.1016/j.bbagen.2008.09.001. View

20.

Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S . Mineralized tissue cells are a principal source of FGF23. Bone. 2007; 40(6):1565-73. DOI: 10.1016/j.bone.2007.01.017. View